000 | 01580 a2200409 4500 | ||
---|---|---|---|
005 | 20250513040605.0 | ||
264 | 0 | _c19931203 | |
008 | 199312s 0 0 eng d | ||
022 | _a0028-3908 | ||
024 | 7 |
_a10.1016/0028-3908(93)90145-s _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZarnowski, T | |
245 | 0 | 0 |
_a2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice. _h[electronic resource] |
260 |
_bNeuropharmacology _cSep 1993 |
||
300 |
_a895-900 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnticonvulsants _xantagonists & inhibitors |
650 | 0 | 4 |
_aAtaxia _xchemically induced |
650 | 0 | 4 |
_aAvoidance Learning _xdrug effects |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aElectroshock |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMemory _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aPsychomotor Performance _xdrug effects |
650 | 0 | 4 |
_aQuinoxalines _xantagonists & inhibitors |
650 | 0 | 4 |
_aSeizures _xprevention & control |
650 | 0 | 4 |
_aalpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid _xantagonists & inhibitors |
700 | 1 | _aKleinrok, Z | |
700 | 1 | _aTurski, W A | |
700 | 1 | _aCzuczwar, S J | |
773 | 0 |
_tNeuropharmacology _gvol. 32 _gno. 9 _gp. 895-900 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0028-3908(93)90145-s _zAvailable from publisher's website |
999 |
_c7693585 _d7693585 |